Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8299 USD | -0.71% |
|
+7.31% | -74.23% |
Jul. 09 | Immunic Names President/COO, Chief Development Officer | MT |
Jul. 09 | Immunic Names Jason Tardio as COO, Werner Gladdines as Chief Development Officer | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
OVID THERAPEUTICS INC. | Bio Therapeutic Drugs | -0.71% | +7.31% | -74.23% | -75.59% | -69.38% | 59.3M | ![]() | ![]() | ![]() |
- Stock Market
- Equities
- OVID Stock
- Charts Ovid Therapeutics Inc.
- Relative Strength Chart